Search research articles
Contact Us
Filters
Showing results (81-90 of 135) with videos related to
Page
of 14
Sort By:
Plos One
|
January 5, 2021
Cohort profile: Study on Zika virus infection in Brazil (ZIKABRA study)
Guilherme Amaral Calvet, Edna Oliveira Kara, Sihem Landoulsi, et al.
BMC Infectious Diseases
|
June 1, 2022
Myopericarditis associated with acute Zika virus infection: a case report
Camila Helena Aguiar Bôtto-Menezes, Izabella Picinin Safe, Ana Cláudia da Cunha Ferreira, et al.
Emerging Infectious Diseases
|
October 11, 2022
Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand
Yifan Li, Mélanie Merbah, Suzanne Wollen-Roberts, et al.
The Pan African Medical Journal
|
November 10, 2025
Mitigating the surge of mpox in Africa: capacity building through public outreach, sample and case management training for healthcare workers and veterinarians
Michael Onyebuchi Iroezindu, Abdulwasiu Bolaji Tiamiyu, Zahra Folasade Parker, et al.
Open Forum Infectious Diseases
|
September 13, 2021
Serological and RT-PCR Surveillance for COVID-19 in an Asymptomatic US Army Trainee Population
Shilpa Hakre, Aaron D Sanborn, Stephen W Krauss, et al.
Science Translational Medicine
|
October 16, 2015
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O Ngwuta, Man Chen, Kayvon Modjarrad, et al.
Science Translational Medicine
|
December 15, 2017
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
Peter Abbink, Rafael A Larocca, Kittipos Visitsunthorn, et al.
The Lancet. Infectious Diseases
|
July 4, 2020
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial
Kathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, et al.
Emerging Infectious Diseases
|
January 25, 2024
Evidence of Zika Virus Reinfection by Genome Diversity and Antibody Response Analysis, Brazil
Marcia da Costa Castilho, Ana Maria Bispo de Filippis, Lais Ceschini Machado, et al.
Journal of Virology
|
March 9, 2018
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape
Lingshu Wang, Wei Shi, James D Chappell, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 135) with videos related to
Sort By:
Page
of 14
Plos One
|
January 5, 2021
Cohort profile: Study on Zika virus infection in Brazil (ZIKABRA study)
Guilherme Amaral Calvet, Edna Oliveira Kara, Sihem Landoulsi, et al.
BMC Infectious Diseases
|
June 1, 2022
Myopericarditis associated with acute Zika virus infection: a case report
Camila Helena Aguiar Bôtto-Menezes, Izabella Picinin Safe, Ana Cláudia da Cunha Ferreira, et al.
Emerging Infectious Diseases
|
October 11, 2022
Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand
Yifan Li, Mélanie Merbah, Suzanne Wollen-Roberts, et al.
The Pan African Medical Journal
|
November 10, 2025
Mitigating the surge of mpox in Africa: capacity building through public outreach, sample and case management training for healthcare workers and veterinarians
Michael Onyebuchi Iroezindu, Abdulwasiu Bolaji Tiamiyu, Zahra Folasade Parker, et al.
Open Forum Infectious Diseases
|
September 13, 2021
Serological and RT-PCR Surveillance for COVID-19 in an Asymptomatic US Army Trainee Population
Shilpa Hakre, Aaron D Sanborn, Stephen W Krauss, et al.
Science Translational Medicine
|
October 16, 2015
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O Ngwuta, Man Chen, Kayvon Modjarrad, et al.
Science Translational Medicine
|
December 15, 2017
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
Peter Abbink, Rafael A Larocca, Kittipos Visitsunthorn, et al.
The Lancet. Infectious Diseases
|
July 4, 2020
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial
Kathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, et al.
Emerging Infectious Diseases
|
January 25, 2024
Evidence of Zika Virus Reinfection by Genome Diversity and Antibody Response Analysis, Brazil
Marcia da Costa Castilho, Ana Maria Bispo de Filippis, Lais Ceschini Machado, et al.
Journal of Virology
|
March 9, 2018
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape
Lingshu Wang, Wei Shi, James D Chappell, et al.
Page
of 14